Please assess the completion status of the following clinical trial:

Trial Title: Subject Information and Consent Form F1J-US-HMCB Duloxetine Once-Daily Dosing Versus Placebo in Patients With Major Depression and Pain

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* You must be suffering from symptoms of depression for at least the past 2 weeks (sadness, loss of interest in daily activities, feelings of hopelessness or guilt, sleeplessness or lack of energy)~* You must have pain symptoms with no known cause, such as unexplainable, head, chest, or back pain, overall aches and pains, or other unexplainable pains.~* You need to be available to visit a doctor's office about once a week for 10 weeks.~Exclusion Criteria:~* You are a woman and are pregnant or breastfeeding.~* You have a current or previous diagnosis of bipolar disorder, schizophrenia, or other psychotic disorder.~* You have had a primary diagnosis of an anxiety disorder within the past 6 months.~* You have a history of alcohol or drug dependence or abuse within the past 6 months.~* You have a serious medical illness.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).